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The	   vasculature	   of	   the	   bone	   marrow	   remains	   poorly	   characterized,	   although	   crucial	   to	   maintain	  
hematopoiesis	   and	   retain	   stem	   cells	   in	   a	   quiescent	   state.	   A	   recent	   study	   by	   Itkin	   et	   al.	   in	  Nature	  
reports	  how	  vascular	  barrier	   integrity	  and	  endothelial	  cell	  metabolism	  regulate	  hematopoietic	  stem	  
cell	  quiescence	  and	  leukocyte	  trafficking.	  
	  
MAIN	  TEXT	  
The	   best-­‐known	   function	   of	   blood	   vessels,	   and	   of	   their	   lining	   endothelial	   cells	   (ECs),	   is	   to	   supply	  
oxygen	   and	  nutrients	   to	   tissues,	   but	   blood	   vessels	   are	   also	   conduits	   for	   hematopoietic	   cells	   during	  
immune	  surveillance.	  Indeed,	  in	  the	  bone	  marrow	  (BM)	  (a	  prime	  site	  of	  hematopoiesis),	  ECs	  control	  
trafficking	  of	  leukocytes	  to	  and	  from	  the	  marrow.	  BM	  blood	  vessels	  also	  have	  perfusion-­‐independent	  
functions,	  such	  as	  creating	  a	  vascular	  niche	  for	  hematopoietic	  stem	  and	  progenitor	  cells	  (HSPCs).	  An	  
outstanding	   question	   was	   whether	   leukocyte	   trafficking	   and	   hematopoietic	   stem	   cell	   (HSC)	  
preservation	  occur	  at	  the	  same	  vascular	  site.	  Earlier	  studies	  identified	  sinusoidal	  vessels	  and	  arterioles	  
as	  vascular	  niches	  for	  HSPCs	  (Kiel	  et	  al.,	  2005;	  Kunisaki	  et	  al.,	  2013;	  Ludin	  et	  al.,	  2014).	  Using	  improved	  
real-­‐time	   imaging	   techniques,	   Itkin	   et	   al.	   (2016)	   now	   report	   that	   arterial	   ECs	   in	   the	   BM	   (aBMECs)	  
create	   an	   endosteal	   vascular	   niche	   for	   non-­‐active	   quiescent	   HSCs,	   while	   sinusoidal	   ECs	   (sBMECs)	  
constitute	  an	  exclusive	  site	  for	  leukocyte	  trafficking	  and	  HSPC	  activation	  (Figure).	  Hypothesizing	  that	  
reactive	  oxygen	  species	   (ROS)	   regulate	  HSC	  quiescence,	   the	  authors	  made	  the	   fascinating	  discovery	  
that	  only	  ROSlow	  HSPCs,	  believed	  to	  contain	  the	  most	  primitive	  long-­‐term	  repopulating	  HSCs	  (Jang	  and	  
Sharkis,	  2007),	  were	  detected	  at	  aBMEC	  niches,	  while	  ROShigh	  HSPCs,	  known	  to	  be	  less	  primitive,	  were	  
detected	  at	  sBMEC	  niches.	  This	  was	  unexpected,	  as	  aBMECs	  are	  exposed	  to	  higher	  oxygen	  levels	  and	  
thus	  prone	  to	  higher	  ROS	  production,	  which	  these	  ECs	  seemingly	  counteract	  by	  relying	  on	  glycolysis.	  





The	   Itkin	   et	   al.	   (2016)	   study	   is	   also	   special,	   as	   they	   define	   for	   the	   first	   time	   an	   important	   role	   for	  
vascular	  barrier	   integrity	   in	  hematopoiesis.	   Indeed,	   aBMECs	  have	  a	   less	  permeable	   vascular	  barrier	  
than	   sBMECs,	  which	  protects	   perivascular	   cells	   against	   access	   to	  blood-­‐borne	  ROS-­‐inducing	   agents.	  
Hence,	   BMEC	   barrier	   disruption	   promotes	   leukocyte	   trafficking	   at	   the	   expense	   of	   stem	   cell	  
maintenance,	   through	  an	   increase	   in	  ROS	   levels	   in	  HPSCs.	  Manipulating	   the	  mechanical	  barrier	  and	  
metabolism	  of	  BM	  vessels	  may	  have	  implications	  for	  HSC	  transplantation	  and	  mobilization	  strategies.	  	  
	   While	  ECs	   line	  blood	  vessels	   in	  all	   tissues,	   they	  vary	   in	  structure	  and	  function,	  even	  within	  a	  
single	  tissue,	   in	  order	  to	  fulfill	  vascular	  bed-­‐specific	  needs	  (Aird,	  2012).	   Itkin	  et	  al.	   (2016)	  show	  that	  
ECs	   in	   different	   BM	   vascular	   beds	   exhibit	   prominent	   differences.	   Arterioles	   in	   the	   endosteal	   zone	  
sustain	  HSC	  quiescence,	  while	  sinusoids	  are	  an	  exclusive	  site	  of	  leukocyte	  trafficking.	  Notably,	  aBMECs	  
have	   a	   different	   anatomical,	   hemodynamic,	   molecular,	   and	   metabolic	   signature	   as	   compared	   to	  
sBMECs.	   Indeed,	   they	   line	   small	   arteries	  or	  arterioles	  with	  higher	   flow	  and	  shear	   rates,	  are	   located	  
primarily	   in	   endosteal	   regions,	   are	   enwrapped	   by	   mural	   pericytes	   (arteries)	   or	   HSC-­‐supportive	  
mesenchymal	  stromal	  precursor	  cells	  (arterioles),	  and	  express	  nestin	  and	  Sca-­‐1.	  These	  vessels	  are	  less	  
permeable	   due	   to	   higher	   expression	   of	   junctional	   proteins	   like	   VE-­‐Cadherin.	   Metabolically,	   even	  
though	   they	   are	   exposed	   to	   higher	   oxygen	   levels	   and	   thus	   are	   expected	   to	   rely	  more	  on	  oxidative	  
metabolism	  (which	  can	  produce	  ROS	  as	  byproducts),	  they	  have	  lower	  ROS	  levels,	  presumably	  because	  
they	  rely	  more	  on	  glycolysis	  than	  sBMECs.	  Conversely,	  more	  permeable	  fenestrated	  sinusoids	  induce	  
higher	  ROS	  in	  their	  surroundings,	  and	  have	  slower	  blood	  flow	  in	  their	  wider	  lumen	  (offering	  a	  greater	  
surface	  for	  cell	  exchange),	  hence	  serving	  as	  an	  ideal	  site	  for	  cell	  trafficking.	  	  
These	   distinct	   identities	   also	   confer	   distinct	   functional	   destinies	   to	   aBMECs	   versus	   sBMECs.	  
Indeed,	  quiescent	  HSCs,	  which	  are	  averse	  to	  high	  ROS	  conditions,	  thrive	  best	   in	  the	  less	  permeable,	  
ROSlow	   aBMEC	   niche,	   while	   trafficking	   leukocytes	   take	   profit	   of	   the	   more	   permeable	   sBMEC	   site,	  
where	  ROShigh	  conditions	  promote	  HSPC	  mobilization	  and	  differentiation	  (Itkin	  et	  al.,	  2016;	  Ludin	  et	  





al.,	  2014).	   Interestingly,	   if	   the	  metabolic	   (ROS)	  state	  was	   ignored,	  the	  physical	  distribution	  of	  HSPCs	  
was	  random	  among	  distinct	  BM	  regions	  (Itkin	  et	  al.,	  2016).	  The	  Itkin	  et	  al.	  (2016)	  study	  thus	  provides	  
another	  layer	  of	  complexity	  while	  at	  the	  same	  time	  simplifying	  the	  existing	  model	  that	  depicts	  both	  
sinusoidal	  and	  arteriolar	  vessels	  as	  vascular	  niches	  (Kiel	  et	  al.,	  2005;	  Kunisaki	  et	  al.,	  2013;	  Ludin	  et	  al.,	  
2014).	   Earlier	   studies	   argued	   that	   ECs	   and	   perivascular	   cells	   in	   these	   niches	   produce	   signals	   that	  
control	  HSC	  maintenance,	  expansion	  and	  lineage-­‐specific	  differentiation	  (Kunisaki	  et	  al.,	  2013;	  Ludin	  
et	   al.,	   2014).	   Itkin	   et	   al.	   (2016)	   now	   argue	   a	   clear	   separation	   of	   HSC	   quiescence	   and	   leukocyte	  
trafficking	  at	  distinct	  vascular	  sites.	  While	  this	  is	  now	  shown	  for	  the	  first	  time,	  an	  earlier	  study	  already	  
provided	  suggestive	  evidence	  for	  functionally	  separate	  BMEC	  sites.	   Indeed,	  computational	  modeling	  
argued	  that	  the	  association	  of	  HSPCs	  with	  sBMECs	  was	  rather	  random,	  whereas	  the	  association	  with	  
arterioles,	  occupying	  only	  1%	  of	  the	  BM	  volume,	  was	  highly	  significant	  (Kunisaki	  et	  al.,	  2013).	  	  
The	   Itkin	   et	   al.	   (2016)	   study	   discovered	   a	   previously	   unrecognized	   role	   for	   vascular	  
permeability	   in	   modulating	   HSC	   quiescence	   and	   leukocyte	   trafficking.	   Using	   pharmacological	   and	  
genetic	   approaches,	   Itkin	   et	   al.	   show	   that	   manipulating	   the	   BMEC	   barrier	   affects	   hematopoiesis.	  
Rendering	  the	  barrier	  more	  leaky	  compromised	  HSC	  quiescence	  at	  the	  aBMEC	  site,	  while	  promoting	  
HSPC	   mobilization	   and	   differentiation,	   and	   increasing	   bidirectional	   trafficking	   at	   the	   sBMEC	   site.	  
Barrier	   integrity	  of	  BMECs	   is	   linked	  to	  ROS	   levels	   in	  HSPCs,	  as	  ROS	  production	  seems	  to	  be	  a	  direct	  
response	   to	   increased	   leakiness	   and	  exposure	   to	  blood	  plasma,	  which	   can	  penetrate	   the	  BM	  more	  
easily	  via	  fenestrated	  sinusoids	  (Itkin	  et	  al.,	  2016).	  Of	  note,	  ROS	  may	  not	  only	  be	  the	  result	  of	  barrier	  
permeability,	  but	  ROS	  may	  also	  causally	  promote	  EC	  barrier	  disruption	  (Eelen	  et	  al.,	  2015).	  	  
Quiescent	  HSCs	  attempt	  to	  keep	  ROS	  levels	  low	  (Ludin	  et	  al.,	  2014).	  In	  agreement,	  HSCs	  have	  
fewer	   mitochondria	   than	   hematopoietic	   progenitors	   (and	   thus	   generate	   less	   ROS	   in	   oxidative	  
metabolism),	   and	   their	   quiescent	   state	  depends	  on	  higher	   rates	  of	   glycolysis	   (Takubo	  et	   al.,	   2013).	  





Since	  oxygen	  levels	  in	  the	  peri-­‐arteriolar	  BM	  regions	  are	  2-­‐fold	  higher	  than	  in	  peri-­‐sinusoidal	  regions	  
(Spencer	  et	  al.,	  2014),	  glycolysis	  in	  HSCs	  may	  enable	  them	  to	  minimize	  ROS	  exposure.	  	  	  
The	  Itkin	  et	  al.	  study	  also	  raises	  questions.	  Itkin	  et	  al.	  suggest	  that	  aBMECs	  rely	  on	  glycolysis	  to	  
create	  a	  ROSlow	  environment	  for	  HSCs.	  A	  more	  in	  depth	  metabolic	  characterization	  of	  BMEC	  subtypes	  
will	   be	   advantageous	   to	   confirm	   this	   hypothesis.	   Also,	   do	   aBMECs	   and	   sBMECs	   differ	   in	   other	  
metabolic	  aspects,	  important	  for	  HSC	  quiescence	  versus	  cell	  trafficking?	  Which	  metabolism	  pathways	  
ECs	  are	  geared	  to	  use,	  can	  determine	  their	  phenotype	  (De	  Bock	  et	  al.,	  2013).	  Further	  characterization	  
of	  BMEC	  metabolism	  might	  yield	  interesting	  novel	  insights.	  	  
The	  Itkin	  et	  al.	  study	  may	  also	  have	  implications	  for	  stem	  cell	  therapy,	  requiring	  mobilization	  
of	   HSCs	   while	   maintaining	   repopulating	   abilities.	   An	   exciting	   question	   is	   whether	   induction	   of	  
hyperpermeability,	   to	   decrease	   retention	   of	   HSCs	   in	   their	   arteriolar	   niche,	   can	   improve	   collection	  
efficacy.	   Conversely,	   tightening	   the	   BMEC	   barrier	   may	   be	   beneficial	   to	   promote	   BM	   lodging	   and	  
engraftment	   of	   transplanted	   HSCs.	   Another	   intriguing	   question	   is	   whether	   inhibiting	   oxidative	  
metabolism	  of	  BMECs	  and	  HSCs,	  thus	  possibly	  rendering	  them	  more	  glycolytic,	  would	  be	  beneficial.	  
Finding	  an	  answer	  to	  these	  potentially	  clinically	  relevant	  questions	  will	  be	  an	  exciting	  journey.	  	  
FIGURE	   LEGEND:	  Vascular	  BM	  niches	  with	  distinct	  vascular	  barrier	  and	  metabolism	  features,	  which	  
can	  be	  manipulated	  therapeutically.	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